Market Tracker

09/22 3:49am ET

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Sep 21
 -0.58 / -0.68%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+12.22% 3 years+17.49%
3 months+7.75% 5 years+22.05%
1 year+24.12% Since inception+15.48%
Data through 09/22/2017

Quote Details

Previous close$85.17
Open day’s range84.49 – 85.68
Net asset value (NAV)84.53 (09/21/2017)
Daily volume3,080,745
Average volume (3 months)4,020,412
Data as of 7:59pm ET, 09/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.05%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.841.13
Net assets$4.1B$3.1B
Average market cap$5.2B$32.0B
Average P/E--22.7
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
KITE Kite Pharma Inc3.59%
EXEL Exelixis Inc2.69%
JUNO Juno Therapeutics Inc2.57%
ALXN Alexion Pharmaceuticals Inc2.40%
VRTX Vertex Pharmaceuticals Inc2.32%
ACAD ACADIA Pharmaceuticals Inc2.30%
NBIX Neurocrine Biosciences Inc2.30%
GILD Gilead Sciences2.29%
SRPT Sarepta Therapeutics Inc2.27%
CLVS Clovis Oncology Inc2.23%